Cargando…

The need for increased pragmatism in cardiovascular clinical trials

The majority of cardiovascular randomized controlled trials (RCTs) test interventions in selected patient populations under explicitly protocol-defined settings. Although these ‘explanatory’ trial designs optimize conditions to test the efficacy and safety of an intervention, they limit the generali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Usman, Muhammad Shariq, Van Spall, Harriette G. C., Greene, Stephen J., Pandey, Ambarish, McGuire, Darren K., Ali, Ziad A., Mentz, Robert J., Fonarow, Gregg C., Spertus, John A., Anker, Stefan D., Butler, Javed, James, Stefan K., Khan, Muhammad Shahzeb
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112643/ https://www.ncbi.nlm.nih.gov/pubmed/35581337 http://dx.doi.org/10.1038/s41569-022-00705-w

Ejemplares similares

Robustness of outcomes in trials evaluating sodium–glucose co‐transporter 2 inhibitors for heart failure
por: Usman, Muhammad Shariq, et al.
Publicado: (2022)

Renin–angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta‐analysis
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2017)

Frailty and heart failure: State‐of‐the‐art review
por: Talha, Khawaja M., et al.
Publicado: (2023)

Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta‐analysis
por: Butler, Javed, et al.
Publicado: (2020)

Application of the Reverse Fragility Index to Statistically Nonsignificant Randomized Clinical Trial Results
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020)

Cardiovascular implications of COVID-19 versus influenza infection: a review
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020)

Discontinuation and non‐publication of heart failure randomized controlled trials: a call to publish all trial results
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020)

Reporting and interpretation of subgroup analyses in heart failure randomized controlled trials
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020)

Cardiovascular Safety Reporting in Contemporary Breast Cancer Clinical Trials
por: Hamid, Arsalan, et al.
Publicado: (2022)

Effect of Carillon Mitral Contour System on patient‐reported outcomes in functional mitral regurgitation: an individual participant data meta‐analysis
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2021)

Reply: Alternative Models of Cardiac Rehabilitation Delivery Urgently Needed to Improve Access for Heart Failure Patients
por: Keshvani, Neil, et al.
Publicado: (2021)

Recognizing the Significance of Outpatient Worsening Heart Failure
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020)

Causes of hospitalization in the USA between 2005 and 2018
por: Salah, Husam M, et al.
Publicado: (2021)

Response to Comment on Segar et al. Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score. Diabetes Care 2019;42:2298–2306
por: Segar, Matthew W., et al.
Publicado: (2020)

A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19
por: Usman, Muhammad Shariq, et al.
Publicado: (2020)

Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure
por: Packer, Milton, et al.
Publicado: (2023)

Pharmaco‐disparities in heart failure: a survey of the affordability of guideline recommended therapy in 10 countries
por: Averbuch, Tauben, et al.
Publicado: (2023)

Targeting Mitochondrial Function in Heart Failure: Makes Sense But Will it Work?
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2019)

Sodium–Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 Diabetes
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2019)

Glucocentric Drugs in Cardiovascular Disease Protection and Heart Failure
por: Talha, Khawaja M., et al.
Publicado: (2022)

Heterogeneity of health status treatment response with sacubitril/valsartan: insights from the CHAMP‐HF registry
por: Khariton, Yevgeniy, et al.
Publicado: (2020)

Ferric carboxymaltose for the treatment of iron‐deficient heart failure patients: a systematic review and meta‐analysis
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020)

Mental health disorders and readmissions following acute myocardial infarction in the United States
por: Sreenivasan, Jayakumar, et al.
Publicado: (2022)

Trends in Anticoagulation Prescription Spending Among Medicare Part D and Medicaid Beneficiaries Between 2014 and 2019
por: Duvalyan, Angela, et al.
Publicado: (2021)

Identifying a low‐flow phenotype in heart failure with preserved ejection fraction: a secondary analysis of the RELAX trial
por: Patel, Kershaw V., et al.
Publicado: (2019)

Empagliflozin, calcium, and SGLT1/2 receptor affinity: another piece of the puzzle
por: Anker, Stefan D., et al.
Publicado: (2018)

Sodium–glucose co‐transporter 2 inhibitors as an early, first‐line therapy in patients with heart failure and reduced ejection fraction
por: Tomasoni, Daniela, et al.
Publicado: (2022)

Urban–rural disparities in diabetes-related mortality in the USA 1999–2019
por: Kobo, Ofer, et al.
Publicado: (2022)

Dear colleagues: enough with the men-only author panels
por: Van Spall, Harriette G C, et al.
Publicado: (2022)

COVID-19 and Katrina: recalcitrant racial disparities
por: Van Spall, Harriette G C, et al.
Publicado: (2020)

Transitional care quality indicators to assess quality of care following hospitalisation for chronic obstructive pulmonary disease and heart failure: a systematic review protocol
por: Michael, Faith, et al.
Publicado: (2019)

New treatments for hyperkalaemia: clinical use in cardiology
por: Vijayakumar, Shilpa, et al.
Publicado: (2019)

Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis
por: Salah, Husam M., et al.
Publicado: (2022)

Systematic review of academic bullying in medical settings: dynamics and consequences
por: Averbuch, Tauben, et al.
Publicado: (2021)

Patiromer use in patients with heart failure: lessons and clinical considerations from the DIAMOND trial
por: Butler, Javed, et al.
Publicado: (2022)

SGLT-2 Inhibitors in Heart Failure: A Review of Current Evidence
por: Talha, Khawaja M., et al.
Publicado: (2023)

Carat, clarity, colour, and cut: grading the DIAMOND trial
por: Butler, Javed, et al.
Publicado: (2023)

Identifying patients at increased risk for poor outcomes from heart failure with reduced ejection fraction: the PROMPT‐HF risk model
por: DeVore, Adam D., et al.
Publicado: (2021)

Applications of digital technology in COVID-19 pandemic planning and response
por: Whitelaw, Sera, et al.
Publicado: (2020)

Trends and characteristics of hospitalizations for heart failure in the United States from 2004 to 2018
por: Salah, Husam M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5vgtkpo6l59k19cc09oli0lmhs